Evidence map›Paper›PMID 42314146›Full record

ArticleJMIR medical informatics2026

Performance of Zero-Shot Classifiers for Categorizing RCT Abstracts by Intervention Type: Validation Study.

Diana Buitrago-Garcia, Delphine S Courvoisier, Sami Capderou, Michele Iudici, Denis Mongin

Abstract readValidation Study
In one paragraph

Article in JMIR medical informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Diana Buitrago-GarciaDivision of Rheumatology, Geneva University Hospitals and University of Geneva, Rue Alcide-Jentzer 22, Genève, 1205, Switzerland, 41 022 372 36 78.ORCID 0000-0001-9761-206X
Delphine S CourvoisierDivision of Rheumatology, Geneva University Hospitals and University of Geneva, Rue Alcide-Jentzer 22, Genève, 1205, Switzerland, 41 022 372 36 78.ORCID 0000-0002-1956-2607
Sami CapderouDivision of Rheumatology, Geneva University Hospitals and University of Geneva, Rue Alcide-Jentzer 22, Genève, 1205, Switzerland, 41 022 372 36 78.
Michele IudiciDivision of Rheumatology, Geneva University Hospitals and University of Geneva, Rue Alcide-Jentzer 22, Genève, 1205, Switzerland, 41 022 372 36 78.ORCID 0000-0001-5871-8806
Denis MonginDivision of Rheumatology, Geneva University Hospitals and University of Geneva, Rue Alcide-Jentzer 22, Genève, 1205, Switzerland, 41 022 372 36 78.ORCID 0000-0002-4801-8395

Funding

Swiss National Science Foundation 212393
6 · The paper itself

Abstract

Background: Artificial intelligence has gained relevance due to its potential to reduce the workload in evidence synthesis or bibliometric projects. While the main focus has been lately on the use of instruction-tuned large language models, zero-shot classification models have not been tested for such task. These models are large language models trained on large datasets of labeled data able to categorize text among proposed labels, irrespective of the text domain or the topic. They are relatively small, able to run on consumer-grade computers, and almost hyperparameter-free. Objective: In our study, we use abstracts of randomized clinical trials in rheumatology as a case example to evaluate the performance of openly available, generalist, zero-shot classification models in classifying types of interventions against a human gold standard. Methods: We classified all rheumatology RCT abstracts published between 2009 and 2022 (n=1,054) as "drug" or "non-drug" using two zero-shot text classification models (DeBERTa and BART) and few-shot prompting using Llama3 8B. Different labeling of categories provided to the zero-shot classification models and different prompts provided to Llama3 8B were tested. Performance was evaluated using accuracy and predictive value of both categories against a human gold standard. Results: Most randomized controlled trials, RCTs (452/1054, 42.9%) assessed drug interventions. The DeBERTa model achieved the highest accuracy (929/1054, 88.1%; 95% CI 86%-90%) when using the "drug" and "non-drug" labels. Llama3 8B and few-shot prompting had slightly higher accuracy and predictive values. Both zero-shot and Llama3 8B models had performance on par with a human without experience in evidence synthesis (905/1054, 85.9%; 95% CI 83.6%-87.8% accuracy). Misclassifications occurred for trials where the intervention was harder to classify, such as procedures (eg, intra-articular injections), food compounds, vitamins, supplements, or biological treatments. Conclusions: This study shows the potential of zero-shot classification models for simple classification tasks, demonstrating accuracy comparable to that of an untrained human. These models are potential tools to streamline systematic review tasks for bibliometric studies in classifying abstracts by supplementing one reviewer.

Indexed as

Abstracting and IndexingArtificial IntelligenceRandomized Controlled Trials as TopicClassification AlgorithmsHumansLarge Language Modelsautomation toolsevidence synthesislarge language modelsLLMmethodology

Identifiers

PMID42314146
PMCPMC13278612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.